Genotypic and Functional Impact of HIV-1 Adaptation to Its Host Population during the North American Epidemic
暂无分享,去创建一个
M. Carrington | B. Walker | J. Fuchs | P. Harrigan | S. Buchbinder | M. Markowitz | M. Schechter | J. Carlson | A. Poon | K. Mayer | Z. Brumme | C. Brumme | M. Brockman | B. Koblin | A. Le | M. Milloy | D. Chopera | Tristan J. Markle | E. Martin | A. Shahid | P. Mwimanzi | L. Cotton | Xiaomei T. Kuang | B. Chan | G. Anmole | P. Nassab | K. Penney | Manal A. Rahman | T. Wagner | Gursev Anmole | Mary Carrington | Kenneth H. Mayer
[1] Rosemary M. McCloskey,et al. Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes , 2013, Retrovirology.
[2] Laurent Tran,et al. Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic , 2013, PLoS pathogens.
[3] D. Richman,et al. Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs , 2013, The Lancet.
[4] B. Walker,et al. Dynamic range of Nef functions in chronic HIV-1 infection. , 2013, Virology.
[5] Victor Appay,et al. A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells. , 2013, Immunity.
[6] Sergei L. Kosakovsky Pond,et al. FUBAR: a fast, unconstrained bayesian approximation for inferring selection. , 2013, Molecular biology and evolution.
[7] F. Pereyra,et al. Attenuation of multiple Nef functions in HIV-1 elite controllers , 2013, Retrovirology.
[8] David Heckerman,et al. Significant Reductions in Gag-Protease-Mediated HIV-1 Replication Capacity during the Course of the Epidemic in Japan , 2012, Journal of Virology.
[9] R. Siliciano,et al. Developing strategies for HIV-1 eradication. , 2012, Trends in immunology.
[10] Z. Brumme,et al. HLA class I sequence-based typing using DNA recovered from frozen plasma. , 2012, Journal of immunological methods.
[11] Michael Rayment,et al. Prevention of HIV-1 infection with early antiretroviral therapy , 2012, Journal of Family Planning and Reproductive Health Care.
[12] A. McLean,et al. Cytotoxic T-Lymphocyte Escape Mutations Identified by HLA Association Favor Those Which Escape and Revert Rapidly , 2012, Journal of Virology.
[13] Tommy F. Liu,et al. Automating HIV Drug Resistance Genotyping with RECall, a Freely Accessible Sequence Analysis Tool , 2012, Journal of Clinical Microbiology.
[14] Huldrych F. Günthard,et al. Whole Genome Deep Sequencing of HIV-1 Reveals the Impact of Early Minor Variants Upon Immune Recognition During Acute Infection , 2012, PLoS pathogens.
[15] D. Heckerman,et al. Widespread Impact of HLA Restriction on Immune Control and Escape Pathways of HIV-1 , 2012, Journal of Virology.
[16] David Heckerman,et al. Correlates of Protective Cellular Immunity Revealed by Analysis of Population-Level Immune Escape Pathways in HIV-1 , 2012, Journal of Virology.
[17] G. Gottlieb,et al. Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission , 2012, AIDS.
[18] D. Heckerman,et al. CTL Responses of High Functional Avidity and Broad Variant Cross-Reactivity Are Associated with HIV Control , 2012, PloS one.
[19] B. Berkhout,et al. Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic , 2011, AIDS.
[20] M. John,et al. Extensive HLA-driven viral diversity following a narrow-source HIV-1 outbreak in rural China. , 2011, Blood.
[21] D. Heckerman,et al. Influence of Gag-Protease-Mediated Replication Capacity on Disease Progression in Individuals Recently Infected with HIV-1 Subtype C , 2011, Journal of Virology.
[22] David V Glidden,et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. , 2010, The New England journal of medicine.
[23] Angela R. McLean,et al. Modelling the Evolution and Spread of HIV Immune Escape Mutants , 2010, PLoS pathogens.
[24] Sergei L. Kosakovsky Pond,et al. Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology , 2010, Bioinform..
[25] Lynn Morris,et al. Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women , 2010, Science.
[26] Todd M. Allen,et al. Early Selection in Gag by Protective HLA Alleles Contributes to Reduced HIV-1 Replication Capacity That May Be Largely Compensated for in Chronic Infection , 2010, Journal of Virology.
[27] E. Bunnik,et al. Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level , 2010, Nature Medicine.
[28] Evan Wood,et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study , 2010, The Lancet.
[29] David Heckerman,et al. Gag-Protease-Mediated Replication Capacity in HIV-1 Subtype C Chronic Infection: Associations with HLA Type and Clinical Parameters , 2010, Journal of Virology.
[30] S. Buus,et al. Efficacious Early Antiviral Activity of HIV Gag- and Pol-Specific HLA-B*2705-Restricted CD8+ T Cells , 2010, Journal of Virology.
[31] O. Gascuel,et al. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. , 2010, Systematic biology.
[32] J. Mullins,et al. Virus-Specific CD8+ T-Cell Responses Better Define HIV Disease Progression than HLA Genotype , 2010, Journal of Virology.
[33] Jerome H. Kim,et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. , 2009, The New England journal of medicine.
[34] Sergei L. Kosakovsky Pond,et al. An Evolutionary Model-Based Algorithm for Accurate Phylogenetic Breakpoint Mapping and Subtype Prediction in HIV-1 , 2009, PLoS Comput. Biol..
[35] Ard van Sighem,et al. Viral Load Levels Measured at Set-Point Have Risen Over the Last Decade of the HIV Epidemic in the Netherlands , 2009, PloS one.
[36] M. Prins,et al. Multiple transmissions of a stable human leucocyte antigen-B27 cytotoxic T-cell-escape strain of HIV-1 in The Netherlands , 2009, AIDS.
[37] C. Rouzioux,et al. No evidence of a change in HIV-1 virulence since 1996 in France , 2009, AIDS (London).
[38] David Heckerman,et al. Adaptation of HIV-1 to human leukocyte antigen class I , 2009, Nature.
[39] D. Hazuda,et al. The Challenge of Finding a Cure for HIV Infection , 2009, Science.
[40] David Heckerman,et al. HLA Footprints on Human Immunodeficiency Virus Type 1 Are Associated with Interclade Polymorphisms and Intraclade Phylogenetic Clustering , 2009, Journal of Virology.
[41] S. Frost,et al. Detecting signatures of selection from DNA sequences using Datamonkey. , 2009, Methods in molecular biology.
[42] Todd M. Allen,et al. Transmission and Long-Term Stability of Compensated CD8 Escape Mutations , 2008, Journal of Virology.
[43] C. Seoighe,et al. Frequent Toggling between Alternative Amino Acids Is Driven by Selection in HIV-1 , 2008, PLoS pathogens.
[44] Todd M. Allen,et al. Protective HLA Class I Alleles That Restrict Acute-Phase CD8+ T-Cell Responses Are Associated with Viral Escape Mutations Located in Highly Conserved Regions of Human Immunodeficiency Virus Type 1 , 2008, Journal of Virology.
[45] M. Carrington,et al. HLA-Associated Clinical Progression Correlates with Epitope Reversion Rates in Early Human Immunodeficiency Virus Infection , 2008, Journal of Virology.
[46] Todd M. Allen,et al. HLA-Associated Alterations in Replication Capacity of Chimeric NL4-3 Viruses Carrying gag-protease from Elite Controllers of Human Immunodeficiency Virus Type 1 , 2008, Journal of Virology.
[47] H. Salomón,et al. HLA-Driven Convergence of HIV-1 Viral Subtypes B and F Toward the Adaptation to Immune Responses in Human Populations , 2008, PloS one.
[48] David Heckerman,et al. Marked Epitope- and Allele-Specific Differences in Rates of Mutation in Human Immunodeficiency Type 1 (HIV-1) Gag, Pol, and Nef Cytotoxic T-Lymphocyte Epitopes in Acute/Early HIV-1 Infection , 2008, Journal of Virology.
[49] D. Heckerman,et al. Central Role of Reverting Mutations in HLA Associations with Human Immunodeficiency Virus Set Point , 2008, Journal of Virology.
[50] H. Schuitemaker,et al. Molecular Evolution of Human Immunodeficiency Virus Type 1 upon Transmission between Human Leukocyte Antigen Disparate Donor-Recipient Pairs , 2008, PloS one.
[51] J. Margolick,et al. Lack of Evidence for Changing Virulence of HIV-1 in North America , 2008, PloS one.
[52] David Heckerman,et al. Statistical Resolution of Ambiguous HLA Typing Data , 2008, PLoS Comput. Biol..
[53] S. Oka,et al. CTL-Mediated Selective Pressure Influences Dynamic Evolution and Pathogenic Functions of HIV-1 Nef1 , 2008, The Journal of Immunology.
[54] A. Rambaut,et al. The emergence of HIV/AIDS in the Americas and beyond , 2007, Proceedings of the National Academy of Sciences.
[55] A. Rambaut,et al. BEAST: Bayesian evolutionary analysis by sampling trees , 2007, BMC Evolutionary Biology.
[56] Todd M. Allen,et al. Escape from the Dominant HLA-B27-Restricted Cytotoxic T-Lymphocyte Response in Gag Is Associated with a Dramatic Reduction in Human Immunodeficiency Virus Type 1 Replication , 2007, Journal of Virology.
[57] Ben Berkhout,et al. Survey of the temporal changes in HIV-1 replicative fitness in the Amsterdam Cohort. , 2007, Virology.
[58] D. Nickle,et al. Reconstruction and Function of Ancestral Center-of-Tree Human Immunodeficiency Virus Type 1 Proteins , 2007, Journal of Virology.
[59] Philip J. R. Goulder,et al. Compensatory Mutation Partially Restores Fitness and Delays Reversion of Escape Mutation within the Immunodominant HLA-B*5703-Restricted Gag Epitope in Chronic Human Immunodeficiency Virus Type 1 Infection , 2007, Journal of Virology.
[60] B. Walker,et al. Effective T-Cell Responses Select Human Immunodeficiency Virus Mutants and Slow Disease Progression , 2007, Journal of Virology.
[61] D. Heckerman,et al. Founder Effects in the Assessment of HIV Polymorphisms and HLA Allele Associations , 2007, Science.
[62] D. Richman,et al. Maintenance of Nef-Mediated Modulation of Major Histocompatibility Complex Class I and CD4 after Sexual Transmission of Human Immunodeficiency Virus Type 1 , 2007, Journal of Virology.
[63] A. Phillips,et al. Temporal trends in postseroconversion CD4 cell count and HIV load: the Concerted Action on Seroconversion to AIDS and Death in Europe Collaboration, 1985-2002. , 2007, The Journal of infectious diseases.
[64] E. Arts,et al. Is HIV-1 evolving to a less virulent form in humans? , 2007, Nature Reviews Microbiology.
[65] D. Nickle,et al. Sources of variation in ancestral sequence reconstruction for HIV-1 envelope genes , 2006, Evolutionary bioinformatics online.
[66] D. Cornforth,et al. HIV-1 Epitope-Specific CD8+ T Cell Responses Strongly Associated with Delayed Disease Progression Cross-Recognize Epitope Variants Efficiently1 , 2006, The Journal of Immunology.
[67] Sebastian Bonhoeffer,et al. Stable virulence levels in the HIV epidemic of Switzerland over two decades , 2006, AIDS.
[68] B. Walker,et al. Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1 , 2006, Journal of Virology.
[69] S. Ho,et al. Relaxed Phylogenetics and Dating with Confidence , 2006, PLoS biology.
[70] Todd M. Allen,et al. Use of a novel GFP reporter cell line to examine replication capacity of CXCR4- and CCR5-tropic HIV-1 by flow cytometry. , 2006, Journal of virological methods.
[71] Mathieu Fourment,et al. PATRISTIC: a program for calculating patristic distances and graphically comparing the components of genetic change , 2006, BMC Evolutionary Biology.
[72] Galit Alter,et al. De Novo Generation of Escape Variant-Specific CD8+ T-Cell Responses following Cytotoxic T-Lymphocyte Escape in Chronic Human Immunodeficiency Virus Type 1 Infection , 2005, Journal of Virology.
[73] E. Arts,et al. Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time , 2005, AIDS.
[74] D. Richman,et al. Confronting the emergence of drug-resistant HIV type 1: impact of antiretroviral therapy on individual and population resistance. , 2005, AIDS research and human retroviruses.
[75] Andrew K. Sewell,et al. Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA , 2005, The Journal of experimental medicine.
[76] Sergei L. Kosakovsky Pond,et al. HyPhy: hypothesis testing using phylogenies , 2005, Bioinform..
[77] D. Cooper,et al. Frequent Transmission of Cytotoxic-T-Lymphocyte Escape Mutants of Human Immunodeficiency Virus Type 1 in the Highly HLA-A24-Positive Japanese Population , 2004, Journal of Virology.
[78] Philip J. R. Goulder,et al. HIV and SIV CTL escape: implications for vaccine design , 2004, Nature Reviews Immunology.
[79] Todd M. Allen,et al. HIV evolution: CTL escape mutation and reversion after transmission , 2004, Nature Medicine.
[80] Stephen J O'Brien,et al. The influence of HLA genotype on AIDS. , 2003, Annual review of medicine.
[81] B. Walker,et al. Gradual adaptation of HIV to human host populations: good or bad news? , 2003, Nature Medicine.
[82] F. Kirchhoff,et al. Enhanced CD4 Down-modulation by Late Stage HIV-1 nef Alleles Is Associated with Increased Env Incorporation and Viral Replication* , 2003, Journal of Biological Chemistry.
[83] John D. Storey,et al. Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[84] Anne-Mieke Vandamme,et al. U.S. Human Immunodeficiency Virus Type 1 Epidemic: Date of Origin, Population History, and Characterization of Early Strains , 2003, Journal of Virology.
[85] Feng Gao,et al. Diversity Considerations in HIV-1 Vaccine Selection , 2002, Science.
[86] C. Moore,et al. Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level , 2002, Science.
[87] M. Mulligan,et al. Magnitude of Functional CD8+ T-Cell Responses to the Gag Protein of Human Immunodeficiency Virus Type 1 Correlates Inversely with Viral Load in Plasma , 2002, Journal of Virology.
[88] M. Carrington,et al. HLA and AIDS: a cautionary tale. , 2001, Trends in molecular medicine.
[89] Michael Bunce,et al. Evolution and transmission of stable CTL escape mutations in HIV infection , 2001, Nature.
[90] J. Bradford,et al. The evolution of the Fenway Community Health model. , 2001, American journal of public health.
[91] T. Greenough,et al. Modulation of Different Human Immunodeficiency Virus Type 1 Nef Functions during Progression to AIDS , 2001, Journal of Virology.
[92] S. Buchbinder,et al. Apparent founder effect during the early years of the San Francisco HIV type 1 epidemic (1978-1979). , 2000, AIDS research and human retroviruses.
[93] A. Lapedes,et al. Timing the ancestor of the HIV-1 pandemic strains. , 2000, Science.
[94] Hiv Survival,et al. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis , 2000, The Lancet.
[95] F. Marincola,et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[96] E. Vittinghoff,et al. Long-term survival after infection with human immunodeficiency virus type 1 (HIV-1) among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1995. , 1999, American journal of epidemiology.
[97] T. Heeren,et al. The social context of drinking, drug use, and unsafe sex in the Boston Young Men Study. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[98] B. Walker,et al. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes , 1998, Nature.
[99] Xiping Wei,et al. Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.
[100] I. Keet,et al. Temporal trends of the natural history of HIV-1 infection following seroconversion between 1984 and 1993. , 1996, AIDS.
[101] R. Swanstrom,et al. Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo , 1993, Journal of virology.
[102] S. Buchbinder,et al. Epidemiology of human immunodeficiency virus type 1 infection among homosexual men participating in hepatitis B vaccine trials in Amsterdam, New York City, and San Francisco, 1978-1990. , 1993, American journal of epidemiology.
[103] S. Rowland-Jones,et al. Human immunodeficiency virus variants that escape cytotoxic T-cell recognition. , 1992, AIDS research and human retroviruses.
[104] Charles R. M. Bangham,et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.
[105] G. Rutherford,et al. Estimating AIDS infection rates in the San Francisco cohort. , 1988, AIDS.
[106] M. Schechter,et al. The Vancouver Lymphadenopathy-AIDS Study: 6. HIV seroconversion in a cohort of homosexual men. , 1986, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[107] B. Wiggs,et al. The Vancouver Lymphadenopathy-AIDS Study: 2. Seroepidemiology of HTLV-III antibody. , 1985, Canadian Medical Association journal.
[108] M. Schechter,et al. The Vancouver Lymphadenopathy-AIDS Study: 1. Persistent generalized lymphadenopathy. , 1985, Canadian Medical Association journal.